Item request has been placed!
×
Item request cannot be made.
×
Processing Request
The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8804070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5640 (Electronic) Linking ISSN: 09543007 NLM ISO Abbreviation: Eur J Clin Nutr Subsets: MEDLINE
- Publication Information:
Publication: <2003->: London : Nature Publishing Group
Original Publication: London : J. Libbey, c1988-
- Subject Terms:
- Abstract:
Background/objectives: Colonic fermentation of dietary fiber to short-chain fatty acids (SCFA) may protect against obesity and diabetes, but excess production of colonic SCFA has been implicated in the promotion of obesity. We aimed to compare the effects of two fermentable fibers on postprandial SCFA and second-meal glycemic response in healthy overweight or obese (OWO) vs lean (LN) participants.
Subjects/methods: Using a randomized crossover design, 13 OWO and 12 LN overnight fasted participants were studied for 6 h on three separate days after consuming 300 ml water containing 75 g glucose (GLU) as control or with 24 g inulin (IN) or 28 g resistant starch (RS). A standard lunch was served 4 h after the test drink.
Results: Within the entire group, compared with control, IN significantly increased serum SCFA (P<0.001) but had no effect on free-fatty acids (FFA) or second-meal glucose and insulin responses. In contrast, RS had no significant effect on SCFA but reduced FFA rebound (P<0.001) and second-meal glucose (P=0.002) and insulin responses (P=0.024). OWO had similar postprandial serum SCFA and glucose concentrations but significantly greater insulin and FFA than LN. However, the effects of IN and RS on SCFA, glucose, insulin and FFA responses were similar in LN and OWO.
Conclusions: RS has favorable second-meal effects, likely related to changes in FFA rather than SCFA concentrations. However, a longer study may be needed to demonstrate an effect of RS on SCFA. We found no evidence that acute increases in SCFA after IN reduce glycemic responses in humans, and we were unable to detect a significant difference in SCFA responses between OWO vs LN subjects.
Competing Interests: The authors declared no conflict of interest
- References:
J Agric Food Chem. 2012 Dec 5;60(48):11928-34. (PMID: 23136915)
Eur J Clin Nutr. 2006 Sep;60(9):1092-9. (PMID: 16523203)
Intern Med J. 2003 Jul;33(7):291-6. (PMID: 12823674)
Nutr Diabetes. 2014 Jun 30;4:e121. (PMID: 24979150)
Cell. 2014 Nov 6;159(4):789-99. (PMID: 25417156)
J Am Coll Nutr. 1998 Dec;17(6):609-16. (PMID: 9853541)
Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1337-46. (PMID: 25761741)
Endocr Connect. 2014 Apr 15;3(2):75-84. (PMID: 24671124)
Nature. 2006 Dec 21;444(7122):1027-31. (PMID: 17183312)
Diabetologia. 2003 May;46(5):659-65. (PMID: 12712245)
Endocrinology. 2008 Sep;149(9):4519-26. (PMID: 18499755)
Med Sci Sports Exerc. 1997 Jun;29(6 Suppl):S1-205. (PMID: 9243481)
Diabetes. 2010 Dec;59(12):3049-57. (PMID: 20876719)
Anaerobe. 2013 Oct;23:74-81. (PMID: 23831725)
Biosci Biotechnol Biochem. 2007 May;71(5):1236-43. (PMID: 17485860)
Diabetes Care. 1995 Jul;18(7):962-70. (PMID: 7555557)
Am J Vet Res. 1997 Nov;58(11):1238-42. (PMID: 9361885)
Acta Med Scand. 1972 Oct;192(4):337-42. (PMID: 5081072)
Microbiome. 2013 Jan 09;1(1):3. (PMID: 24467987)
Cell. 2014 Jan 16;156(1-2):84-96. (PMID: 24412651)
Diabet Med. 2010 Apr;27(4):391-7. (PMID: 20536509)
Int J Obes (Lond). 2014 Dec;38(12):1525-31. (PMID: 24642959)
Am J Clin Nutr. 2005 Sep;82(3):559-67. (PMID: 16155268)
Med Sci Sports Exerc. 1993 Jan;25(1):71-80. (PMID: 8292105)
Obesity (Silver Spring). 2010 Jan;18(1):190-5. (PMID: 19498350)
Br J Nutr. 2010 Jul;104(1):83-92. (PMID: 20205964)
J Nutr. 2008 Mar;138(3):439-42. (PMID: 18287346)
Res Vet Sci. 1998 Mar-Apr;64(2):91-6. (PMID: 9625462)
Am J Clin Nutr. 2006 Apr;83(4):817-22. (PMID: 16600933)
Br J Nutr. 2005 Apr;93 Suppl 1:S163-8. (PMID: 15877890)
J Lipid Res. 1968 Jul;9(4):509-12. (PMID: 5725882)
Eur J Clin Nutr. 2012 Sep;66(9):1029-34. (PMID: 22828730)
Br J Nutr. 2013 Mar 14;109(5):914-9. (PMID: 23200109)
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5. (PMID: 16033867)
J Diabetes. 2011 Mar;3(1):58-66. (PMID: 21040500)
Br J Nutr. 2008 Dec;100(6):1192-9. (PMID: 18405402)
Br J Nutr. 2013 Oct;110(8):1429-33. (PMID: 23507477)
PLoS One. 2009 Sep 23;4(9):e7125. (PMID: 19774074)
Can J Microbiol. 2016 Aug;62(8):692-703. (PMID: 27314511)
Nutr Rev. 2011 Jan;69(1):9-21. (PMID: 21198631)
Diabetes. 1990 Jul;39(7):775-81. (PMID: 2191884)
Am J Gastroenterol. 1989 Sep;84(9):1027-33. (PMID: 2773895)
J Clin Endocrinol Metab. 2012 Sep;97(9):3326-32. (PMID: 22745235)
Appl Physiol Nutr Metab. 2010 Feb;35(1):9-16. (PMID: 20130660)
Eur J Clin Nutr. 2008 Jun;62(6):712-20. (PMID: 17522615)
Br J Nutr. 2010 Jan;103(1):82-90. (PMID: 19664300)
Eur J Clin Nutr. 2011 Dec;65(12):1279-86. (PMID: 21712835)
- Grant Information:
64648-1 Canada Canadian Institutes of Health Research; 486906 Canada CIHR
- Molecular Sequence:
ClinicalTrials.gov NCT02562014
- Accession Number:
0 (Blood Glucose)
0 (Fatty Acids, Volatile)
0 (Insulin)
9005-25-8 (Starch)
9005-80-5 (Inulin)
- Publication Date:
Date Created: 20161215 Date Completed: 20180110 Latest Revision: 20240313
- Publication Date:
20240313
- Accession Number:
PMC5298923
- Accession Number:
10.1038/ejcn.2016.248
- Accession Number:
27966565
No Comments.